Literature DB >> 21439895

Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.

Qiong-lan Tang1, Song Fan, Hai-gang Li, Wei-liang Chen, Xi-ming Shen, Xiao-ping Yuan, Shao-hai Chang, Yang Song.   

Abstract

Cysteine-rich protein 61 (Cyr61) selectively binds heparin and insulin-like growth factors and mediates a variety of biological actions, including cell adhesion, differentiation, proliferation, migration, angiogenesis, and tumorigenesis. Cyr61 is also a prognostic factor for tumor progression and survival of individuals with various types of tumors. This study investigated the relationship between the expression level of Cyr61 and clinicopathological features, as well as the prognostic significance of Cyr61 expression in human salivary adenoid cystic carcinoma (SACC). The expression of Cyr61 and Ki-67, a cell-proliferation marker, was examined immunohistochemically in paraffin embedded tissue specimens from 60 SACC patients who underwent radical surgery between 1995 and 2004. A chi-square test was used to investigate the relationship between Cyr61 and Ki-67 expression and clinicopathological features. Survival analysis was performed to determine the prognostic significance of Cyr61 expression. Cyr61 expression was observed in 39 cases (39/60, 65%) of SACC, and Cyr61 expression was positively correlated with Ki-67 expression (P=0.002). A high expression of Cyr61 was significantly associated with solid subtype, perineural invasion, vascular invasion or cancer embolus, advanced stage, recurrence, and metastasis (P<0.05). The survival rate of patients with high expression of Cyr61 or Ki67 was significantly lower than that of patients with low expression. Multivariate Cox's proportional hazards analysis showed that vascular invasion, TNM stage, recurrence, distant metastasis, Ki-67 expression, and Cyr61 expression were independent prognostic factors of overall survival (P<0.05). Cyr61 expression is significantly correlated with Ki-67 expression and may have potential value in screening high-risk cases for recurrence and metastasis, as well as identifying poor prognosis in SACC patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439895     DOI: 10.1016/j.oraloncology.2011.02.022

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Expression of LC3, LAMP2, KEAP1 and NRF2 in Salivary Adenoid Cystic Carcinoma.

Authors:  Cong-Fa Huang; Wei-Wei Deng; Lu Zhang; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Pathol Oncol Res       Date:  2015-09-08       Impact factor: 3.201

2.  Pigmented adenoid cystic carcinoma of the ear skin arising from the epidermis: a case report with immunohistochemical studies.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

3.  Adenoid cystic carcinoma of the oral cavity: immunohistochemical study of four cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

4.  Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.

Authors:  Ishrat Mahjabeen; Kashif Ali; Xiaofeng Zhou; Mahmood Akhtar Kayani
Journal:  Tumour Biol       Date:  2014-03-13

5.  Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma.

Authors:  Chunbo Shao; Marietta Tan; Justin A Bishop; Jia Liu; Weiliang Bai; Daria A Gaykalova; Takenori Ogawa; Ami R Vikani; Yuri Agrawal; Ryan J Li; Myoung Sook Kim; William H Westra; David Sidransky; Joseph A Califano; Patrick K Ha
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma.

Authors:  You-Hua Jiang; Bo Cheng; Ming-Hua Ge; Gu Zhang
Journal:  Head Neck Oncol       Date:  2012-03-27

7.  CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.

Authors:  Joana Cardoso; Marta Mesquita; António Dias Pereira; Mónica Bettencourt-Dias; Paula Chaves; José B Pereira-Leal
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

8.  Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.

Authors:  Wei Dai; Yuan Yao; Qing Zhou; Chang-fu Sun
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.